Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1
G Qian, L Zhu, C Huang, Y Liu, Y Ren, Y Ding… - International …, 2020 - Elsevier
Type I interferons are broadly used for antiviral therapy in clinical. However, the IFNs-
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …
Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1
G Qian, L Zhu, C Huang, Y Liu… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Type I interferons are broadly used for antiviral therapy in clinical. However, the IFNs-
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …
Ubiquitin specific protease 5 negatively regulates the IFNs-mediated antiviral activity via targeting SMURF1.
G Qian, L Zhu, C Huang, Y Liu, Y Ren… - International …, 2020 - europepmc.org
Type I interferons are broadly used for antiviral therapy in clinical. However, the IFNs-
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …
mediated antiviral efficacy is commonly restricted by negative regulators. Here, we show that …